Chromatin Remodeling and Cancer
Chromatin Remodeling and Cancer is a research topic within Molecular Biology. Science Explorer counts 8.8k research works in it since 1952. 18.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the role of chromatin remodeling, particularly the SWI/SNF complexes and ARID1A mutations, in cancer development and progression. It explores the impact of these mutations on epigenetic regulation, tumor suppression, genomic analysis, oncogenic transformation, and synthetic lethality. Additionally, it delves into the involvement of chromatin remodeling in mammalian development.
- Chromatin Remodeling
- SWI/SNF Complexes
- ARID1A Mutations
- Cancer
- Epigenetics
- Tumor Suppressor
- Genomic Analysis
- Oncogenic Transformation
- Synthetic Lethality
- Mammalian Development
- Research works
- 8.8k fractional, since 1952
- In the world top 10%
- 1.6k per year above
- Top-10% rate
- 18.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +39% the tick is no change
Which countries lead Chromatin Remodeling and Cancer research?
By volume, the United States and China publish the most (613 and 556 works in 2022–2025).
By volume, 2022–2025
- 1 United States 613 works
- 2 China 556 works
- 3 Japan 108 works
- 4 Germany 96 works
- 5 India 76 works
- 6 United Kingdom 68 works
- 7 Italy 65 works
- 8 Canada 56 works
- 9 France 55 works
- 10 Spain 35 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Chromatin Remodeling and Cancer research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Chromatin Remodeling and Cancer research, followed by University of North Carolina at Chapel Hill and Johns Hopkins University.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 20 works
- 2 University of North Carolina at Chapel HillUnited States 13 works
- 3 Johns Hopkins UniversityUnited States 13 works
- 4 Memorial Sloan Kettering Cancer CenterUnited States 12 works
- 5 Nanjing Medical UniversityChina 10 works
- 6 Harvard UniversityUnited States 9 works
- 7 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 9 works
- 8 Sichuan UniversityChina 9 works
- 9 St. Jude Children's Research HospitalUnited States 8 works
- 10 Dana-Farber Cancer InstituteUnited States 8 works
Who are the leading researchers in Chromatin Remodeling and Cancer?
The most-cited researchers publishing on Chromatin Remodeling and Cancer include Gordon B. Mills, John D. Minna and Andreas von Deimling.
- 1 Gordon B. Mills United States 3.7k citations
- 2 John D. Minna United States 2.5k citations
- 3 Andreas von Deimling Germany 2.4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Chromatin Remodeling and Cancer research done?
The largest centres of Chromatin Remodeling and Cancer research in 2022–2025 are Shanghai (China), Beijing (China), Guangzhou (China) and Houston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Houston and Baltimore.
Largest cities, 2022–2025
Where it is the local speciality
- HoustonUS · 33.6 works6.8×
- BaltimoreUS · 25.4 works5.3×
Location quotient: how much more of its research is in Chromatin Remodeling and Cancer than the world average.
Where is the best place to study Chromatin Remodeling and Cancer?
Among universities, judged by research, Harvard University, Nanjing Medical University and Johns Hopkins University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Harvard UniversityUnited States | 45.2 | 28.3% | 3.8× | 9 | +37.5% |
| 2 | Nanjing Medical UniversityChina | 43.9 | 6.5% | 10.2× | 10 | +259.4% |
| 3 | Johns Hopkins UniversityUnited States | 33.1 | 10.6% | 6.1× | 13 | +47.8% |
| 4 | Sichuan UniversityChina | 33.0 | 19.0% | 2.6× | 9 | +195.4% |
| 5 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 31.4 | 17.9% | 4.8× | 9 | +101.9% |
| 6 | University of North Carolina at Chapel HillUnited States | 19.6 | 9.3% | 3.8× | 13 | +67.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Chromatin Remodeling and Cancer research growing?
Output in 2018–2022 was 39% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Chromatin Remodeling and Cancer.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.